After the London Whale trading fiasco, many investors have sworn off allocating any of their funds to JPMorgan Chase (NYSE:JPM) and often point to lack of trust as their reason.

Motley Fool writers Ilan Moscovitz and John Reeves recently laid out why they wouldn't touch JPMorgan's stock

However, in classic Fool fashion, health-care analyst Max Macaluso sought to hear the other side of the story and sat down with banking analyst David Hanson. In this video, David acknowledges the hesitation to trust the JPMorgan management team but highlights the enormously profitable enterprise and its bright future.

David Hanson and Max Macaluso, Ph.D., have no position in any stocks mentioned. You can follow David and Max on Twitter. The Motley Fool owns shares of Bank of America, Citigroup, and JPMorgan Chase. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.